when we spoke last time about the astra zeneca deal that was proposed by pfizer, it was obvious that the entire team was going to go home. he will have some synergy within division.gy this is 100% tax and version deals. there are literally no synergies between the countries, so you'll need someone to manage all of ,he franchises, you have no one practically no one to manage them, so i think that they will retain a large portion of management, so i think it's back from management will still be there but will be much lesser extent that you have seen on the astra zeneca, another thing to be taking into account is astra zeneca was somewhat of a national asset, there was some pride involved. conceiveds much less as a proud national asset of great britain. i think this will go smoother than the pfizer deal did. >> let's talk tax. we brought it up, yesterday had taken be saying that the tax and version deals where american companies are trying to avoid their own tax regimes, by up companies such as ireland -- companies in lower tax entries such as ireland. they want to back eight it. could